首页> 外文期刊>Iranian Journal of Microbiology >Isolation and structure elucidation of phenazine derivative from Streptomyces sp. strain UICC B-92 isolated from Neesia altissima (Malvaceae)
【24h】

Isolation and structure elucidation of phenazine derivative from Streptomyces sp. strain UICC B-92 isolated from Neesia altissima (Malvaceae)

机译:STREXTOMYCES SP中苯吡啶衍生物的分离与结构阐明。从Neesia Altissima(Malvaceae)分离的菌株UICC B-92

获取原文
获取外文期刊封面目录资料

摘要

Background and Objectives: Endophytic actinomycetes have been known as a promising source for new antibiotics discovery against susceptible and resistant forms of pathogenic microorganisms. This study was aimed at determining antibacterial compound from Streptomyces sp. strain B-92 isolated from a medicinal plant Neesia altissima . Materials and Methods: Streptomyces sp. strain UICC B-92 was endophytic actinomycetes of N. altissima that obtained from Universitas Indonesia Culture Collection (UICC). Isolation and determination of bioactive compound were carried out using thin layer chromatography (TLC), nuclear magnetic resonance spectroscopy (NMR), and liquid chromatography mass spectrometry (LC-MS) analyses. An in vitro antibacterial assay of pure bioactive compound from the endophytic actinomycetes strain was performed against Bacillus cereus strain ATCC 10876, Escherichia coli strain ATCC 25922, Salmonella typhimurium strain ATCC 25241, Shigella flexneri strain ATCC 12022 and Staphylococcus aureus strain ATCC 25923. Results: The bioactive compound was identified as 4-((3S,4R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl) tetrahydro-2H-pyran-2-yloxy) phenazine-1-carboxylic acid. In vitro antimicrobial assay showed that bioactive compound of Streptomyces sp. strain UICC B-92 exhibited antagonistic activities against two Gram-positive bacteria, viz, B. cereus strain ATCC 10876 and S. aureus strain ATCC 25923. Conclusion: The findings of this research showed that, bioactive compound of Streptomyces sp. strain UICC B-92 is suggested a new compound based on glycoside structure and its position.
机译:背景和目的:内生外形菌被称为新抗生素发现针对易感和抗性的病原微生物形式的有前途的来源。本研究旨在确定来自链霉菌SP的抗菌化合物。菌株B-92与药用植物Neesia Altissima分离。材料与方法:Streptomyces sp。菌株UICC B-92是从Universitas印度尼西亚文化收集(UICC)获得的N.Atrissima的内生放射瘤。使用薄层色谱(TLC),核磁共振光谱(NMR)和液相色谱质谱(LC-MS)分析进行生物活性化合物的分离和测定。来自内生生物菌菌株的纯生物活性化合物的体外抗菌测定对芽孢杆菌菌株ATCC 10876进行大肠杆菌菌株ATCC 25922,Salcella毒蕈菌株ATCC 25241,Shigella Flexeri菌株ATCC 12022和金黄色葡萄球菌菌株ATCC 25923。结果:将生物活性化合物鉴定为4 - ((3S,4R,5S)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基氧基)吩嗪-1-羧酸。体外抗微生物测定表明Streptomyces sp的生物活性化合物。菌株UICC B-92对两种革兰氏阳性细菌的拮抗活性显示出两种革兰氏阳性细菌,B.培养基菌株ATCC 10876和Aureus菌株ATCC 25923.结论:该研究的结果表明,Streptomyces sp的生物活性化合物。菌株UICC B-92是基于糖苷结构及其位置的新化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号